+]±É ʽxn
For Advertisements Please Call India 9891096150 9802153000 USA 516 713 4700 646 598 9111
ÚUæCþUèØ çãU‹Îè ÎñçÙ·¤
ÖæÚUÌ ¥õÚU ¥×ðçÚU·¤æ âð ÂýâæçÚUÌ
ßáü Ñ y ¥´·¤ Ñ vz~
¥æÚU.°Ù.¥æ§üU. Ù´. HARBIL/2017/71370
Publisher & Director: Raj K. Aggarwal
·ñ¤ÍÜ (ãUçÚUØæ‡ææ), ×´»ÜßæÚU, v{ ÁêÙ-w®w®
I Email:- atalhindnews@gmail.com
âßüÎÜèØ ÕñÆ·¤ ×ð´ °·¤ âæÍ ç×Ü·¤ÚU ·¤æ× ·¤ÚUÙð ÂÚU âã×çÌ ÙØè ç΄è(°Áð´âè) ç΄è ×ð´ ·¤ôÚUôÙæ ·Ô¤ Õð·¤æÕê ãôÌð ãæÜæÌ ÂÚU ·Ô¤´ÎýèØ »ëã×´˜æè ¥ç×Ì àææã ·Ô¤ âæÍ âô×ßæÚU âßüÎÜèØ ÕñÆ·¤ ãé§ü çÁâ×ð´ âÖè ÙðÌæ¥ô´ Ùð ÚUæÁÏæÙè ×ð´ ·¤ôÚUôÙæ ·¤è ÚUô·¤Íæ× ·Ô¤ çÜØð °·¤âæÍ ç×Ü·¤ÚU ·¤æ× ·¤ÚUÙð ÂÚU âã×çÌ ÁÌæ§üÐ âæ©Í Üæò·¤ ×ð´ ·¤ÚUèÕ ÇðÉ ƒæ´ÅUæ ¿Üè ÕñÆ·¤ ·Ô¤ ÕæÎ ÕæãÚU ¥æ° ç΄è ÖæÁÂæ ¥ŠØÿæ ¥æÎðàæ »é#æ Ùð ·¤ãæ ç·¤ ÕñÆ·¤ ×ð´ àææç×Ü âÖè ÙðÌæ çÎ„è ·¤ô ·¤ôÚUôÙæ â𠪤ÕæÚUÙð ·Ô¤ çÜØð ç×Ü·¤ÚU ·¤æ× ÂÚU âã×Ì ÍðÐ »é#æ Ùð â´ßæÎÎæÌæ¥ô´ âð ÕæÌ¿èÌ ×ð´ ·¤ãæ »ëã×´˜æè Ùð ÕñÆ·¤ ×ð´ ÕÌæØæ ç·¤ w® ÁêÙ Ì·¤ ç΄è âÚU·¤æÚU ÚUôÁæÙæ ·¤ôçßÇ-v~ ·¤è v} ãÁæÚU
ÂÚU Øã ÌèâÚUè ÕñÆ·¤ ãñÐ ÚUçßßæÚU ·¤ô ÂãÜð ç΄è âÚU·¤æÚU ¥õÚU ÕæÎ ×ð´ ÌèÙô´ çÙ»×ô´ ·Ô¤ ×ãæÂõÚUô´ ·Ô¤ âæÍ ÕñÆ·¤ ·¤ÚU ·¤§ü ×ãˆßÂê‡æü çÙ‡æüØ çÜ° »° ÍðÐ ÕñÆ·¤ô´ ×ð´ ·Ô¤´ÎýèØ SßæS‰Ø ÂçÚUßæÚU ·¤ËØæ‡æ ×´˜æè ãáüßÏüÙ , ©ÂÚUæ’ØÂæÜ ¥çÙÜ ÕñÁÜ,×é Ø×´˜æè ¥ÚUçß´Î ·Ô¤ÁÚUèßæÜ Öè ×õÁêÎ ÍðÐ ·¤ôÚUôÙæ ×æ×Üð ×ð´ ç΄è Îðàæ ×ð´ ÌèâÚUð SÍæÙ ÂÚU ãñÐ ÚUæÁÏæÙè ×ð´ çÂÀÜð ÌèÙ çÎÙ âð Ü»æÌæÚU Îô Áæ´¿ àæéL¤ ·¤ÚU Îð»èÐ ©‹ãô´Ùð ·¤ãæ ·¤æ´»ýðâ ¥ŠØÿæ ¿õÏÚUè ¥çÙÜ ãÁæÚU âð ¥çÏ·¤ â´R¤×‡æ ·Ô¤ çÙØ´˜æ‡æ ÁôÙô´ ×ð´ ƒæÚU-ƒæÚU Áæ·¤ÚU ·¤é×æÚU ¥õÚU ¥æ× ¥æÎ×è ÂæÅUèü ×æ×Üð ¥æ ÚUãð ãñ´Ð ÚUçßßæÚU ·¤ô ·¤ôÚUôÙæ Áæ´¿ ãô»èÐ ç΄è ×ð´ wyw (¥æÂ) ·Ô¤ ÚUæ’ØâÖæ âæâ´Î wwwy çÚU·¤æòÇü ÙØð ×æ×Üô´ âð ·¤´ÅUðÙ×ð´ÅU ÁôÙ ãñÐ àææã ·¤è â´ÁØ çâ´ã ¥õÚU ¥‹Ø àææç×Ü â´R¤ç×Ìô´ ·¤æ ·¤éÜ ¥æ´·¤Ç¸æ ¥ŠØÿæÌæ ×ð´ ÕñÆ·¤ ×ð´ ç΄è ãé°Ð »ëã×´˜æè ·¤è çÂÀÜð wy ƒæ´ÅUô´ yvv}w ¥õÚU ×ëÌ·¤ vxw| ãô ÖæÁÂæ ¥ŠØÿæ ¥æÎðàæ »é#æ, çÎ„è ·Ô¤ ÎõÚU ç΄è ×ð´ ·¤ôÚUôÙæ â´R¤×‡æ »§ü ãñÐ
Îðàæ ×ð´ ·¤ôÚUôÙæ â´R¤ç×Ìô´ ·¤è â´ Øæ x.xw Üæ¹ âð ¥çÏ·¤, ~zw® Üô»ô´ ·¤è ×õÌ ÙØè ç΄è (°Áð´âè) Îðàæ ×ð´ ·¤ôÚUôÙæ ßæØÚUâ(·¤ôçßÇ v~) ·Ô¤ â´R¤×‡æ ·Ô¤ ×æ×Üô´ ·¤æ ÕɸÙæ ÁæÚUè ãñ ÌÍæ çÂÀÜð wy ƒæ´ÅUô´ ·Ô¤ ÎõÚUæÙ ·¤ôÚUæðÙæ â´R¤×‡æ ·Ô¤ âßæüçÏ·¤ vv,z®w ÙØð ×æ×Üð âæ×Ùð ¥æØð ãñ´ ÁÕç·¤ §âè ¥ßçÏ ×ð´ xwz ¥õÚU Üô»ô´ ·¤è ×õÌ ãô »ØèÐ ·Ô¤‹ÎýèØ SßæS‰Ø °ß´ ÂçÚUßæÚU ·¤ËØæ‡æ ×´˜ææÜØ ·¤è ¥ôÚU âð âæð×ßæÚU ·¤ô ÁæÚUè ¥æ´·¤Ç¸ô´ ·Ô¤ ×éÌæçÕ·¤ ÙØð ×æ×Üô´ ·Ô¤ âæÍ â´R¤ç×Ìô´ ·¤è â´ Øæ Õɸ·¤ÚU x,xw,ywy ãô »ØèÐ §â Õè×æÚUè âð ×ÚUÙð ßæÜô´ ·¤è â´ Øæ Öè Õɸ·¤ÚU ~zw® ãô »ØèÐ Îðàæ ×ð´ §â
¥×ðçÚU·¤æ ×ð´ ·¤ôÚUôÙæ ßæØÚUâ ·Ô¤ ×æ×Üð wv Üæ¹ ·Ô¤ ÂæÚU Âãé´¿ð â×Ø ·¤ôÚUôÙæ ·Ô¤ v,zx,v®{ âçR¤Ø ×æ×Üð ãñ´, ÁÕç·¤ §â ×ãæ×æÚUè âð çÙÁæÌ ÂæÙð ßæÜô´ ·¤è â´ Øæ v,{~,|~} ãñÐ ×ãæÚUæcÅþ §â ×ãæ×æÚUè âð Îðàæ ×ð´ âÕâð ¥çÏ·¤ ÂýÖæçßÌ ãé¥æ ãñÐ ÚUæ’Ø ×ð´ çÂÀÜð wy ƒæ´ÅUô´ ×ð´ xx~® ÙØð ×æ×Üð ÎÁü ç·¤Øð »Øð ãñ´ ¥õÚU vw® Üô»ô´ ·¤è ×õÌ ãé§ü ãñÐ
·Ô¤ÁÚUèßæÜ Ùð Üæò·¤Çæ©Ù ·¤è ¥ÅU·¤Üô´ ·¤ô ç·¤Øæ ¹æçÚUÁ ÙØè ç΄è(°Áð´âè) ç΄è ×ð´ ·¤ôÚUôÙæ ßæØÚUâ ·¤è Õð·¤æÕê ãôÌè çSÍçÌ ·Ô¤ ×gðÙÁÚU çȤÚU âð Üæò·¤Çæ©Ù ·¤è ¥ÅU·¤Üô´ ·¤ô ¹æçÚUÁ ·¤ÚUÌð ãé° ×é Ø×´˜æè ¥ÚUçß´Î ·Ô¤ÁÚUèßæÜ Ùð âô×ßæÚU ·¤ô ·¤ãæ °ðâè ·¤ô§ü ØôÁÙæ Ùãè´ ãñÐ ÚUæÁÏæÙè ×ð´ ÁêÙ ×æã ·Ô¤ ÎõÚUæÙ â´R¤×‡æ ·Ô¤ ×æ×Üð ÌðÁè âð Õɸð ãñ´Ð çÂÀÜð ÌèÙ çÎÙ âð ÚUôÁæÙæ Îô ãÁæÚU âð ¥çÏ·¤ ×æ×Üð âæ×Ùð ¥æ° ãñ´Ð ÚUçßßæÚU ·¤ô çÚU·¤æÇü wwwy ×æ×Üð ¥æ° ¥õÚU â´R¤ç×Ìô´ ·¤æ ·¤éÜ ¥æ´·¤Ç¸æ yv,vvw ÂÚU Âãé´¿ »ØæÐ ·¤ôÚUôÙæ ·¤è ÖØæßã ãæÜæÌ Îð¹·¤ÚU Üô» çȤÚU âð Üæò·¤Çæ©Ù ·¤è ¥ÅU·¤Üð´ Ü»æÙð Ü»ð ÍðÐ ·¤éÀ
‹ØêØæò·¤ü/°Áð´âèÐ ÁæòÙ ãæòÂç·¤´â ØêÙèßçâüÅUè ·Ô¤ ¥ÙéâæÚU ¥×ðçÚU·¤æ ×ð´ ·¤ôÚUôÙæ ßæØÚUâ ·Ô¤ ×æ×Üð wv Üæ¹ ·Ô¤ ÂæÚU Âãé´¿ »° ãñ´Ð ØêÙèßçâüÅUè ·Ô¤ ¥ÙéâæÚU ×ð´ ¥×ðçÚU·¤æ ×ð´ ¥Õ Ì·¤ ·¤éÜ wv®®|y~ Üô» ·¤ôÚUôÙæ âð â´R¤ç×Ì ãé° ãñ´ ÁÕç·¤ Øãæ´ ×ÚUÙð ßæÜô´ ·¤æ ¥æ´·¤Ç¸æ Õɸ·¤ÚU vvz}w| Âãé´¿ »Øæ ãñÐ
I
Postal No. KKR/183/2019-22 9891096150/9802153000
¥™ææÙÌæ âð ’ØæÎæ ¹ÌÚUÙæ·¤ °·¤ ÙÁÚU ãôÌæ ãñ ¥ã´·¤æÚUÑ ÚUæãéÜ »æ´Ïè ÖæÚUÌèØ ©‘¿æØô» ·Ô¤ Îô ¥çÏ·¤æÚUè §SÜæ×æÕæÎ ×ð´ ÙØè ç΄è/(°Áð´âè)Ð ·¤æ´»â ðý ·Ô¤ Âêßü ¥ŠØÿæ ÚUæãéÜ »æ´Ïè Ùð Îðàæ ×ð́ ·¤ôÚUôÙæ ßæØÚUâ ·Ô¤ â´R¤×‡æ ·Ô¤ ×æ×Üô´ ×ð́ Ü»æÌæÚU ãô ÚUãè ÕɸôÌÚUè ·¤ô Üð·¤ÚU âô×ßæÚU ·¤ô âÚU·¤æÚU ÂÚU ÂÚUôÿæ M¤Â âð çÙàææÙæ âæÏæ ¥õÚU ·¤ãæ ç·¤ ÖæÚUÌ ×ð́ Ü»æ° »° Üæò·¤Çæ©Ù âð âæçÕÌ ãôÌæ ãñ ç·¤ ¥™ææÙÌæ âð ’ØæÎæ ¹ÌÚUÙæ·¤ ¥ã´·¤æÚU ãôÌæ ãñÐ ©‹ãô´Ùð ×ãæÙ ßñ™ææçÙ·¤ ¥ÜÕÅUü ¥æ§´SÅUèÙ ·Ô¤ °·¤ ·¤ÍÙ ·¤æ ©„ð¹ ·¤ÚUÌð ãé° ÅU÷ßèÅU ç·¤Øæ, ÒÒØã Üæò·¤Çæ©Ù âæçÕÌ ·¤ÚUÌæ ãñ ç·¤ çâȤü °·¤ ¿èÁ ¥™ææÙÌæ âð ’ØæÎæ ¹ÌÚUÙæ·¤ ãñ ¥õÚU ßã ãñ ¥ã´·¤æÚUÐÓÓ ·¤æ´»ýðâ ÙðÌæ Ùð Üæò·¤Çæ©Ù ·Ô¤ ¿æÚUô´ ¿ÚU‡æô´ ×ð́ ·¤ôÚUôÙæ ßæØÚUâ ·Ô¤ ×æ×Üô´ ×ð́ ßëçh
ÜæÂÌæ, Âæ·¤ ·Ô¤ âæ×Ùð ©Ææ ×égæ
âð ÁéÇ¸æ °·¤ »ýæȤ Öè àæðØÚU ç·¤ØæÐ SßæS‰Ø ×´˜ææÜØ ·Ô¤ ×éÌæçÕ·¤ ÖæÚUÌ ×ð´ Ü»æÌæÚU ÌèâÚUð çÎÙ ·¤ôÚUôÙæ ßæØÚUâ â´R¤×‡æ ·Ô¤ vv,®®® âð ’ØæÎæ ×æ×Üð âæ×Ùð ¥æ° ãñ́ ¥õÚU âô×ßæÚU ·¤ô â´R¤×‡æ ·Ô¤ ×æ×Üð Õɸ·¤ÚU x,xw,ywy ãô »°Ð â´R¤×‡æ âð xwz ¥õÚU Üô»ô´ ·¤è ×õÌ ·Ô¤ âæÍ ãè ×ÚUÙð ßæÜô´ ·¤è â´ Øæ ~,zw® ãô »§ü ãñÐ
ÖæÚUÌ ¥õÚU ÙðÂæÜ ·¤æ çÚUàÌæ ÚUôÅUè-ÕðÅUè Áñâæ, ·¤ô§ü Ìæ·¤Ì §âð Ùãè´ ÌôǸ â·¤Ìè Ñ ÚUæÁÙæÍ çâ´ã ÙØè ç΄è(°Áð´âè)Ð ÖæÚUÌ mæÚUæ çÜÂéÜð¹ ÎÚUðü Ì·¤ ÕÙæØè »Øè âǸ·¤ ·Ô¤ ÂêÚUè ÌÚUã ÖæÚUÌèØ ÿæð˜æ ×ð́ ãôÙð ·¤è ÕæÌ ÂÚU ÁôÚU ÎðÌð ãé° ÚUÿææ ×´˜æè ÚUæÁÙæÍ çâ´ã Ùð âô×ßæÚU ·¤ô ·¤ãæ ç·¤ ©Ù·¤è âÚU·¤æÚU ÙðÂæÜ ·Ô¤ âæÍ ÒÒ»ÜÌȤãç×Øô´ÓÓ ·¤ô ÕæÌ¿èÌ ·Ô¤ ÁçÚU° ãÜ ·¤ÚUÙð ×ð´ çßEæâ ÚU¹Ìè ãñÐ çâ´ã Ùð © æÚUæ¹´Ç ·Ô¤ çÜ° °·¤ çÇçÁÅUÜ ÚUñÜè ×ð´ ÎôÙô´ Îðàæô´ ·Ô¤ Õè¿ »ãÚUð â´Õ´Ïô´ ·¤ô ÚUð¹æ´ç·¤Ì ·¤ÚUÌð ãé° ·¤ãæ ç·¤ ©Ù·Ô¤ Õè¿ ÒÒÚUôÅUè ¥õÚU ÕðÅUè Ó ·¤æ â´Õ´Ï ãñ ¥õÚU ÎéçÙØæ ·¤è ·¤ô§ü Ìæ·¤Ì §âð ÌôǸ Ùãè´ â·¤ÌèÐ ©‹ãô´Ùð ·¤ãæ,ÒÒã×æÚUð Õè¿ ·Ô¤ßÜ °ðçÌãæçâ·¤ ¥õÚU âæ´S·¤ëçÌ·¤ â´Õ´Ï Ùãè´ ãñ´ ÕçË·¤ ¥æŠØæçˆ×·¤ â´Õ´Ï Öè ãñ´ ¥õÚU ÖæÚUÌ §âð ·¤Öè ÖêÜ Ùãè´ â·¤ÌæÐÓÓ ©‹ãô´Ùð ·¤ãæ,ÒÒÖæÚUÌ ¥õÚU
ÙðÂæÜ ·Ô¤ Õè¿ â´Õ´Ï ·ñ¤âð ÅUêÅU â·¤Ìð ãñ´?ÓÓ ÎÚU¥âÜ ÙðÂæÜ ·¤è â´âÎ Ùð àæçÙßæÚU ·¤ô Îðàæ ·Ô¤ Ù° ÚUæÁÙèçÌ·¤ Ù Uàæð ·¤ô ¥lÌÙ ·¤ÚUÙð ·Ô¤ çÜ° â´çßÏæÙ ×ð´ â´àæôÏÙ ·Ô¤ çÜ° âßüâ ×çÌ âð ×ÌÎæÙ ç·¤Øæ ãñ´Ð ßã âè×æ ÂÚU ÚU‡æÙèçÌ·¤ M¤Â âð ×ãˆßÂê‡æü ÌèÙ §Üæ·¤ô´ ÂÚU ¥ÂÙæ Îæßæ ·¤ÚU ÚUãæ ãñÐ çâ´ã Ùð ¥ÂÙð â´ÕôÏÙ ×ð´ ·¤ãæ ç·¤ ÖæÚUÌ mæÚUæ ÕÙæ§ü »§ü âǸ·¤ âð ØçÎ ÙðÂæÜ ·Ô¤ Üô»ô´ ×ð´ ·¤ô§ü »ÜÌȤã×è ãé§ü ãñ Ìô ©âð ÕæÌ¿èÌ ·Ô¤ ÁæçÚU° ÎêÚU ç·¤Øæ Áæ°»æÐ ÚUÿææ ×´˜æè Ùð ·¤ãæ ç·¤ ÖæÚUÌ ·Ô¤ Üô»ô´ ·Ô¤ ×Ù ×ð´ ÙðÂæÜ ·Ô¤ çÜ° ·¤ô§ü ·¤Ç¸ßæãÅU ãô ãè Ùãè´ â·¤ÌèÐ ©‹ãô´Ùð ·¤ãæ ç·¤ ×ôÎè âÚU·¤æÚU Ùð ¥Ùé‘ÀðÎ x|® ·¤ô â×æ# ·¤ÚUÙð, ÌèÙ ÌÜæ·¤ ·¤ô â×æ# ·¤ÚUÙð Áñâð ßæÎô´ ·¤ô ÂêÚUæ ç·¤Øæ ãñÐ
ÙØè ç΄è(°Áð´âè)Ð §SÜæ×æÕæÎ ×ð´ ÖæÚUÌèØ ©‘¿æØô» ·Ô¤ Îô ·¤çÙD ¥çÏ·¤æÚUè âô×ßæÚU âéÕã âð ÜæÂÌæ ãñ´Ð âê˜æô´ Ùð ÕÌæØæ ç·¤ Îô ·¤×èü âéÕã °·¤ ßæãÙ ÂÚU ¥æçÏ·¤æçÚU·¤ Ç÷ØêÅUè ·Ô¤ çÜ° ©‘¿æØô» ÁæÙð ·Ô¤ çÜ° çÙ·¤Üð Üðç·¤Ù ßãæ´ Âãé´¿ð Ùãè´Ð âê˜æô´ Ùð ÕÌæØæ ç·¤ ßð Îô ƒæ´ÅUð âð ÜæÂÌæ ãñ´Ð ¥æçÏ·¤æçÚU·¤ ÌõÚU ÂÚU ×æ×Üð ×ð´ ·¤ô§ü ÕØæÙ ÁæÚUè Ùãè´ ç·¤Øæ »Øæ ãñÐ ÖæÚUÌèØ ©‘¿æØô» Ùð Âæç·¤SÌæÙè ¥çÏ·¤æçÚUØô´ ·Ô¤ â×ÿæ ×æ×Üæ ©ÆæØæ ãñÐ ÖæÚUÌ mæÚUæ Âæç·¤SÌæÙ ©‘¿æØô» ·Ô¤ Îô ¥çÏ·¤æçÚUØô´ ·¤ô Áæâêâè ·Ô¤ ¥æÚUô ×ð´ çÙÜ´çÕÌ ç·¤° ÁæÙð ·Ô¤ ·¤éÀ çÎÙ ÕæÎ Øã ƒæÅUÙæ ãé§ü ãñÐ
´¿Ìˆß ×ð´ ÜèÙ ãé¥æ âéàææ´Ì çâ´ã ÚUæÁÂêÌ ·¤æ ÂæçÍüß àæÚUèÚU, çÂÌæ Ùð Îè ×é¹æç‚Ù ×é´Õ§üU/°Áð´âèÐ ÕæòÜèßéÇ ° UÅUÚU âéàææ´Ì çâ´ã ÚUæÁÂêÌ ·¤æ ÂçÍüß àæÚUèÚU ·¤æ ¥´çÌ× â´S·¤æÚU ×é´Õ§ü ·Ô¤ çßÜð ÂæÜðü ·Ô¤ âðßæ â×æÁ ƒææÅU ×ð´ ·¤ÚU çÎØæ »Øæ ãñ´Ð ×é´Õ§ü ×ð´ Ù× ¥æ´¹ô´ âð âéàææ´Ì çâ´ã ÚUæÁÂêÌ ·¤ô ¥æç¹ÚUè çßÎæ§ü Îè »§üÐ çßÜð ÂæÜðü ·Ô¤ âðßæ â×æÁ ƒææÅU ÂÚU ©Ù·¤æ ¥´çÌ× â´S·¤æÚU ÂêÚUè çßçÏ âð ÂçÚUßæÚU ·¤è ×õÁêλè ×ð´ ãé¥æÐ ¥´çÌ× çßÎæ§ü ÎðÙð ·Ô¤ çÜ° çÂÌæ, ¿¿ðÚUð Öæ§ü, ÌèÙô´ ÕãÙð´ ¥õÚU ¥‹Ø ·¤ÚUèÕè ƒææÅU ÂÚU ×õÁêÎ ÚUãðÐ ¥´çÌ× â´S·¤æÚU ·Ô¤ ßQ¤ à×àææÙ ƒææÅU ×ð ·Ô¤ßÜ ÂçÚUßæÚU ·Ô¤ Üô» ·¤éÀ ·¤éÍ ÎôSÌ ãè àææç×Ü ãé°Ð âéàææ´Ì çâ´ã ÚUæÁÂêÌ ·¤æ ÂæçÍüß àæÚUèÚU ÂôSÅU×æÅUü× ·Ô¤ ÕæÎ ·¤ÂêÚU ¥SÂÌæÜ ×ð´ ãè ÍæÐ ÂôSÅU×æÅUü× ÂêÚUæ ãôÙð ·Ô¤ ÕæÎ âèÏð à×àææÙ ƒææÅU ÜæØæ »ØæÐ à×àææÙ ƒææÅU ×ð´ ÂãÜð âð ãè ÌñØæÚUè ·¤è Áæ ¿é·¤è ÍèÐ à×àææÙ ƒææÅU ×ð´ ÂçÚUßæÚU ·Ô¤ Üô» ãè ×õÁêÎ ÍðÐ âéàææ´Ì ·Ô¤ çÂÌæ Ùð ¥ÂÙð xy âæÜ ·Ô¤ ÕðÅUð ·¤ô ×é¹æç‚Ù ÎèÐ âéàææ´Ì çâ´ã ÚUæÁÂêÌ ·¤è ¥´çÌ× Øæ˜ææ ·Ô¤ ÎõÚUæ ×é´Õ§ü ×ð´ ÌðÁ ÕæçÚUàæ Öè ãôÙð Ü»èÐ à×àææÙ ƒææÅU ·Ô¤ ÕæãÚU ÌðÁ ÕæçÚUàæ ãô ÚUãè ÍèÐ ·¤ôÚUôÙæ ßæØÚUÜ ·Ô¤ ¿ÜÌð à×æàææÙ ƒææÅU ×ð´ z® âð ’ØæÎæ Üô»ô´ Ùãè´ Áæ â·¤Ìð §â·Ô¤ çÜ° ·Ô¤ßÜ ÂçÚUßæÚU ·Ô¤ Üô» ãè ßãæ´ ×õÁêÎ ÚUãðÐ âéàææ´Ì ·¤è ¹æâ ÎôSÌ ·¤ãè ÁæÙð ßæÜè çÚUØæ ¿R¤ßÌèü Öè à×àææÙ ƒææÅU ×ð´ ¥æØèÐ ƒææÅU ÂÚU âéàææ´Ì çâ´ã ÚUæÁÂêÌ ·Ô¤ çÂÌæ, ¿¿ðÚUð Öæ§ü, ÌèÙô´ ÕãÙð´ ¥õÚU ¥‹Ø ·¤ÚUèÕè ×õÁêÎ ãñ´Ð §â·Ô¤ ¥Üæßæ Ÿæhæ ·¤ÂêÚU, çßßð·¤ ¥æòÕÚUæØ, âéàææ´Ì ·Ô¤ ·¤éÀ ¹æâ ÎôSÌ à×âæÙ ƒææÅU ·Ô¤ ÕæãÚU ¹Ç¸ð ãé°Ð
ãçÚUØæ‡ææ çàæÿææ çßÖæ» ·¤æ ÕǸæ Èñ¤âÜæ
¥Õ çÕÙæ °â°Üâè ·Ô¤ Öè ãô´»ð °Çç×àæ٠ȤÚUèÎæÕæÎÐãçÚUØæ‡ææ çàæÿææ çßÖæ» Ùð Ù° â˜æ ×ð´ °Çç×àæÙ ÜðÙð ßæÜð Àæ˜æô´ ·Ô¤ çÜ° ÕǸè ÚUæãÌ ÂýÎæÙ ·¤èÐ çàæÿææ çßÖæ» ·Ô¤ §â Èñ¤âÜð âð Âýæ§üßÅð U S·¤êÜ ÀôǸ·¤ÚU âÚU·¤æÚUè S·¤êÜ ×ð´ °Çç×àæÙ ÜðÙð ßæÜô´ Àæ˜æô´ ·¤ô ¥Õ ÂÚUàð ææÙè Ùãè´ ÛæðÜÙè ÂǸ»ð èÐ Âýæ§üßÅð U S·¤êÜ ·Ô¤ Àæ˜æ âÚU·¤æÚUè S·¤êÜ ×ð´ çÕÙæ °â°Üâè ·Ô¤ Öè ¥ÂÙæ Îæç¹Üæ ·¤ÚUßæ â·¤Ìð ãñд ãçÚUØæ‡ææ çßlæÜØ çàæÿææ çÙÎðàææÜØ ·¤è ¥ôÚU âð ÁæÚUè ¥æÎðàæ ×ð´ ÕÌæØæ »Øæ ãñ ç·¤
Brand Ambassador of Satyamev jayate USA Online Kid’s Dance Contest 2020
ÌéÚÚÌ Îæç¹Üæ çÎØæ Áæ°, ßãè´ âÚU·¤æÚUè S·¤êÜ ·¤ô Àæ˜æ ·Ô¤ çÂÀÜð S·¤êÜ ·¤ô ¥æòÙÜæ§Ù °â°Üâè (School Certificate)
âÚU·¤æÚUè çßlæÜØô´ ×ð´ Àæ˜æô´ ·¤è °â°Üâè ·¤è ¥çÙßæØüÌæ ·¤ô ¹ˆ× ç·¤Øæ Áæ ÚUãæ ãñÐ §â çÙ‡æüØ ·¤æ âèÏæ ©gðàØ Øã ãñ ç·¤ ·¤ôçßÇ-v~
·¤è ˜ææâÎè ·Ô¤ ·¤æÚU‡æ Õ‘¿ô´ ·¤è çàæÿææ ÂýÖæçßÌ Ù ãôÙð Âæ°Ð Ù° çÙØ× ·Ô¤ ×éÌæçÕ·¤, âÚU·¤æÚUè S·¤êÜ ×ð´ °Çç×àæÙ ÜðÙð ßæÜð Àæ˜æ ·¤ô
Over 100 New COVID-19 Cases Detected In Beijing In Fresh Outbreak: WHO
Geneva: More than 100 cases of the novel coronavirus have been officially recorded in fresh outbreak in Beijing, the World Health Organization (WHO) said Monday. As lockdown restrictions ease and countries in Europe lifted their borders, the WHO warned countries to stay on alert for a possible resurgence of COVID-19 infections. The UN health agency said it understood no new deaths have been reported thus far in the Chinese capital but added that given Beijing's size and connectivity, the outbreak was a cause for concern. "Even in countries that have demonstrated the ability to suppress transmission, countries must stay alert to the possibility of resurgence," WHO director-general Tedros Adhanom Ghebreyesus told a virtual press conference. "Last week, China reported a new cluster of cases in Beijing, after more than 50 days without a case in that city. More than 100 cases have now been confirmed." "The origin and extent of the outbreak are
×êËØ Ñ w M¤ÂØð
ePaper- Website:www.atalhind.com
¥ÅUÜ çãÚÎ/Øæð»àð æ »»ü
çÎÙ âð âôàæÜ ×èçÇØæ ÂÚU Öè §âð Üð·¤ÚU ¹êÕ È¤Áèü â´Îðàæô´ ·¤è ÖÚU×æÚU ãô ÍèÐ §Ù â´Îðàæô´ ×ð´ çÎËÜè-°Ùâè¥æÚU ·Ô¤ ÖèÌÚU v} ÁêÙ âð â Ì Üæò·¤Çæ©Ù ·¤è ÕæÌ ·¤ãè »§ü ÍèÐ ·Ô¤ÁÚUèßæÜ Ùð §Ù ¥ÅU·¤Üô´ çßÚUæ× Ü»æÌð ãé° ·¤ãæ ç·¤ çÎË?Üè ×ð´ çȤÚU Üæò·¤Çæ©Ù ·¤è ·¤ô§ü ØôÁÙæ Ùãè´ ãñÐ
ÂëDU Ñ }
being investigated." The virus emerged in Wuhan in China in late 2019. It since drove local transmission down to near-zero as the crisis hammered the rest of the world. Maria Van Kerkhove, the WHO's COVID-19 technical lead, told the news conference in Geneva: "My understanding is that there are no deaths associated so far" with the Beijing outbreak. Chinese-led investigation WHO emergencies director Mike Ryan said
that countries which have implemented an immediate and comprehensive spread of measures have generally been able to contain new clusters. "However, Beijing is a large city and a very dynamic and connected city, so there is always a concern," he said. "And I think you can see that level of concern in the response of the Chinese authorities, so we are tracking that very closely." He said the WHO had offered assistance and support to the Chinese authorities leading the probe, and may reinforce its own team in Beijing in the coming days as the investigation grows. "A cluster like this is a concern and it needs to be investigated and controlled -- and that is exactly what the Chinese authorities are doing," said Ryan. The novel coronavirus has killed at least 433,000 people and infected more than 7.9 million since it first emerged in China last December, according to a tally from official sources compiled by AFP.
Leaving
ÁæÚUè ·¤ÚUÙð ·¤æ ¥æ»ýã ç·¤Øæ Áæ°Ð ØçÎ Àæ˜æ ·¤æ S·¤êÜ vz çÎÙô´ ·Ô¤ ¥´ÎÚU °â°Üâè ÁæÚUè Ùãè´ ·¤ÚUÌæ Ìô §âð SßÌ: ãè ÁæÚUè ×æÙ çÜØæ Áæ°»æÐ »õÚUÌÜÕ ãñ ç·¤ çàæÿææ çßÖæ» ·¤ô Øã Öè çàæ·¤æØÌð´ ç×Ü ÚUãè Íè ç·¤ Âýæ§üßÅð U S·¤êÜô´ âð âÚU·¤æÚUè S·¤êÜ ×ð´ ¥æÙð ßæÜð Àæ˜æô´ ·¤è °â°Üâè ÁæÚUè Ùãè´ ·¤è Áæ ÚUãè ãñÐ
US Revokes Emergency Use Status Of Anti-Malarial Drug HCQ In COVID-19 Washington: The United States on Monday withdrew emergency use authorizations for two antimalarial drugs favored by President Donald Trump to treat the new coronavirus, effectively shutting the door on the politically charged treatments. Hydroxychloroquine (HCQ) and chloroquine (CQ) were authorized in March after they were found to inactivate the virus in test tubes, and early small studies appeared to show they worked well in humans, too. Since that time, however, larger, better-controlled experiments have found that the two medicines are ineffective in treating COVID-19 or in preventing infection among people who have been exposed to the virus. Meanwhile, safety concerns have been raised around their use -- particularly the risk of causing irregular heart rhythm in certain patients. "It is no longer reasonable to believe that oral formulations of HCQ and CQ may be effective in treating
COVID-19," Denise Hinton, chief scientist of the Food and Drug Administration (FDA) wrote in a letter. "Nor is it reasonable to believe that the known and potential benefits of these products outweigh their known and potential risk. "Accordingly, FDA revokes the EUA for emergency use of HCQ and CQ to treat COVID-19." The emergency approvals paved the way for the medicines to be donated from a national stockpile to hospitals to fight COVID-19, and were seen as an intermediary step before full regulatory approval.